• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对花粉(早熟禾)致敏小鼠的表皮免疫疗法与舌下免疫疗法的比较

Epicutaneous Immunotherapy Compared with Sublingual Immunotherapy in Mice Sensitized to Pollen (Phleum pratense).

作者信息

Mondoulet Lucie, Dioszeghy Vincent, Ligouis Mélanie, Dhelft Véronique, Puteaux Emilie, Dupont Christophe, Benhamou Pierre-Henri

机构信息

DBV Technologies, R&D Department, 92220 Bagneux, France.

出版信息

ISRN Allergy. 2012 Feb 2;2012:375735. doi: 10.5402/2012/375735. Print 2012.

DOI:10.5402/2012/375735
PMID:23724241
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3658791/
Abstract

Background. The aim of this study was to compare the efficacy of epicutaneous immunotherapy (EPIT) to sublingual immunotherapy (SLIT) in a model of mice sensitized to Phleum pratense pollen. Methods. BALB/c mice were sensitized by sub-cutaneous route to pollen protein extract mixed treated for 8 weeks, using sham, EPIT, or SLIT. Measurements involved the serological response and cytokine profile from reactivated splenocytes, plethysmography after aerosol challenge to pollen, cell, and cytokine contents in the bronchoalveolar lavages (BALs). Results. After immunotherapy, sIgE was significantly decreased in the treated groups compared to sham (P < 0.001), whereas sIgG2a increased with EPIT and SLIT (P < 0.001 and P < 0.005 versus sham). Reactivated splenocytes secreted higher levels of Th2 cytokines with sham (P < 0.01). Penh values were higher in sham than EPIT and SLIT. Eosinophil recruitment in BAL was significantly reduced only by EPIT (P < 0.01). Conclusion. In this model of mice sensitized to pollen, EPIT was at least as efficient as SLIT.

摘要

背景。本研究的目的是在对早熟禾花粉致敏的小鼠模型中比较表皮免疫疗法(EPIT)与舌下免疫疗法(SLIT)的疗效。方法。将BALB/c小鼠通过皮下途径致敏于经处理的花粉蛋白提取物,持续8周,分别采用假处理、EPIT或SLIT。测量指标包括再激活脾细胞的血清学反应和细胞因子谱、花粉气溶胶激发后的体积描记法、支气管肺泡灌洗(BAL)中的细胞和细胞因子含量。结果。免疫治疗后,与假处理组相比,治疗组的sIgE显著降低(P < 0.001),而sIgG2a在EPIT和SLIT组中升高(与假处理组相比,P < 0.001和P < 0.005)。假处理组再激活的脾细胞分泌更高水平的Th2细胞因子(P < 0.01)。假处理组的Penh值高于EPIT和SLIT组。仅EPIT显著减少了BAL中嗜酸性粒细胞的募集(P < 0.01)。结论。在这个对花粉致敏的小鼠模型中,EPIT至少与SLIT一样有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4148/3658791/2601e6110f21/ISRN.ALLERGY2012-375735.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4148/3658791/7b1942d57b95/ISRN.ALLERGY2012-375735.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4148/3658791/6ca4e10228bd/ISRN.ALLERGY2012-375735.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4148/3658791/7a407b387322/ISRN.ALLERGY2012-375735.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4148/3658791/88ebe5c10d04/ISRN.ALLERGY2012-375735.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4148/3658791/2601e6110f21/ISRN.ALLERGY2012-375735.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4148/3658791/7b1942d57b95/ISRN.ALLERGY2012-375735.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4148/3658791/6ca4e10228bd/ISRN.ALLERGY2012-375735.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4148/3658791/7a407b387322/ISRN.ALLERGY2012-375735.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4148/3658791/88ebe5c10d04/ISRN.ALLERGY2012-375735.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4148/3658791/2601e6110f21/ISRN.ALLERGY2012-375735.005.jpg

相似文献

1
Epicutaneous Immunotherapy Compared with Sublingual Immunotherapy in Mice Sensitized to Pollen (Phleum pratense).对花粉(早熟禾)致敏小鼠的表皮免疫疗法与舌下免疫疗法的比较
ISRN Allergy. 2012 Feb 2;2012:375735. doi: 10.5402/2012/375735. Print 2012.
2
Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy.经皮免疫治疗在过敏小鼠模型中使用新的传递系统进行完整皮肤。
Clin Exp Allergy. 2010 Apr;40(4):659-67. doi: 10.1111/j.1365-2222.2009.03430.x. Epub 2009 Dec 10.
3
Differences in phenotype, homing properties and suppressive activities of regulatory T cells induced by epicutaneous, oral or sublingual immunotherapy in mice sensitized to peanut.经皮、口服或舌下免疫疗法诱导的对花生致敏小鼠调节性T细胞的表型、归巢特性及抑制活性差异
Cell Mol Immunol. 2017 Sep;14(9):770-782. doi: 10.1038/cmi.2016.14. Epub 2016 Apr 11.
4
Sublingual immunotherapy in sensitized mice.致敏小鼠的舌下免疫疗法。
Ann Allergy Asthma Immunol. 2007 Apr;98(4):366-72. doi: 10.1016/S1081-1206(10)60884-8.
5
Epicutaneous immunotherapy (EPIT) blocks the allergic esophago-gastro-enteropathy induced by sustained oral exposure to peanuts in sensitized mice.经皮免疫治疗(EPIT)可阻断致敏小鼠持续口服花生诱导的过敏食管-胃-肠病。
PLoS One. 2012;7(2):e31967. doi: 10.1371/journal.pone.0031967. Epub 2012 Feb 21.
6
Shorter dosing intervals of sublingual immunotherapy lead to more efficacious treatment in a mouse model of allergic inflammation.舌下免疫治疗的较短给药间隔可在变应性炎症的小鼠模型中实现更有效的治疗。
Scand J Immunol. 2010 Jun;71(6):403-12. doi: 10.1111/j.1365-3083.2010.02394.x.
7
Intact skin and not stripped skin is crucial for the safety and efficacy of peanut epicutaneous immunotherapy (EPIT) in mice.完整的皮肤而非被剥离的皮肤对于花生皮内免疫治疗(EPIT)在小鼠中的安全性和疗效至关重要。
Clin Transl Allergy. 2012 Nov 12;2(1):22. doi: 10.1186/2045-7022-2-22.
8
Efficacy of sublingual vectorized recombinant Bet v 1a in a mouse model of birch pollen allergic asthma.舌下给予重组矢车菊素 1a 载体在花粉过敏哮喘小鼠模型中的疗效。
Vaccine. 2013 May 28;31(23):2628-37. doi: 10.1016/j.vaccine.2013.03.041. Epub 2013 Apr 10.
9
Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation.草片剂舌下免疫治疗下调 TH2 细胞因子反应,随后产生调节性 T 细胞。
J Allergy Clin Immunol. 2014 Jan;133(1):130-8.e1-2. doi: 10.1016/j.jaci.2013.09.043. Epub 2013 Nov 28.
10
Sublingual immunotherapy reduces allergic symptoms in a mouse model of rhinitis.舌下免疫疗法可减轻鼻炎小鼠模型的过敏症状。
Clin Exp Allergy. 2007 Apr;37(4):488-97. doi: 10.1111/j.1365-2222.2006.02624.x.

引用本文的文献

1
Innovative delivery systems for epicutaneous immunotherapy.经皮免疫治疗的创新给药系统。
Front Immunol. 2023 Aug 22;14:1238022. doi: 10.3389/fimmu.2023.1238022. eCollection 2023.
2
Dose and route of administration determine the efficacy of prophylactic immunotherapy for peanut allergy in a Brown Norway rat model.给药途径和剂量决定了预防免疫疗法在 BN 大鼠花生过敏模型中的疗效。
Front Immunol. 2023 Feb 23;14:1121497. doi: 10.3389/fimmu.2023.1121497. eCollection 2023.
3
Pre-Existing Humoral Immunity Enhances Epicutaneously-Administered Allergen Capture by Skin DC and Their Migration to Local Lymph Nodes.

本文引用的文献

1
Epicutaneous immunotherapy using a new epicutaneous delivery system in mice sensitized to peanuts.经皮免疫治疗在花生致敏小鼠中使用新型经皮给药系统。
Int Arch Allergy Immunol. 2011;154(4):299-309. doi: 10.1159/000321822. Epub 2010 Oct 20.
2
Towards evidence-based medicine in specific grass pollen immunotherapy.迈向基于证据的特异性草花粉免疫治疗。
Allergy. 2010 Apr;65(4):420-34. doi: 10.1111/j.1398-9995.2009.02292.x. Epub 2009 Dec 21.
3
Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy.
预先存在的体液免疫增强皮肤树突状细胞对经皮给予的变应原的捕获及其向局部淋巴结的迁移。
Front Immunol. 2021 Mar 26;12:609029. doi: 10.3389/fimmu.2021.609029. eCollection 2021.
4
The Current State of Epicutaneous Immunotherapy for Food Allergy: a Comprehensive Review.经皮免疫治疗食物过敏的现状:全面综述。
Clin Rev Allergy Immunol. 2018 Oct;55(2):153-161. doi: 10.1007/s12016-017-8650-3.
5
Differences in phenotype, homing properties and suppressive activities of regulatory T cells induced by epicutaneous, oral or sublingual immunotherapy in mice sensitized to peanut.经皮、口服或舌下免疫疗法诱导的对花生致敏小鼠调节性T细胞的表型、归巢特性及抑制活性差异
Cell Mol Immunol. 2017 Sep;14(9):770-782. doi: 10.1038/cmi.2016.14. Epub 2016 Apr 11.
6
Is The Allergen Really Needed in Allergy Immunotherapy?变应原免疫疗法真的需要变应原吗?
Curr Treat Options Allergy. 2015;2(1):72-82. doi: 10.1007/s40521-014-0038-5.
7
Epicutaneous Immunotherapy for Aeroallergen and Food Allergy.气传变应原和食物过敏的表皮免疫疗法
Curr Treat Options Allergy. 2013 Dec 17;1(1):68-78. doi: 10.1007/s40521-013-0003-8. eCollection 2014.
8
New routes for allergen immunotherapy.过敏原免疫治疗的新途径。
Hum Vaccin Immunother. 2012 Oct;8(10):1525-33. doi: 10.4161/hv.21948. Epub 2012 Oct 1.
经皮免疫治疗在过敏小鼠模型中使用新的传递系统进行完整皮肤。
Clin Exp Allergy. 2010 Apr;40(4):659-67. doi: 10.1111/j.1365-2222.2009.03430.x. Epub 2009 Dec 10.
4
Epicutaneous allergen administration: a novel approach for allergen-specific immunotherapy?经皮给予变应原:变应原特异性免疫治疗的一种新方法?
J Allergy Clin Immunol. 2009 Nov;124(5):1003-4. doi: 10.1016/j.jaci.2009.09.049.
5
Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy.表皮给药作为变应原特异性免疫疗法的一种新方法。
J Allergy Clin Immunol. 2009 Nov;124(5):997-1002. doi: 10.1016/j.jaci.2009.07.019. Epub 2009 Sep 5.
6
Identification of three distinct subsets of migrating dendritic cells from oral mucosa within the regional lymph nodes.区域淋巴结内口腔黏膜迁移树突状细胞三个不同亚群的鉴定。
Immunology. 2009 Aug;127(4):558-66. doi: 10.1111/j.1365-2567.2008.03031.x.
7
Mycobacterium bovis BCG killed by extended freeze-drying reduces airway hyperresponsiveness in 2 animal models.经延长冻干法灭活的牛分枝杆菌卡介苗可降低两种动物模型中的气道高反应性。
J Allergy Clin Immunol. 2008 Feb;121(2):471-8. doi: 10.1016/j.jaci.2007.09.033. Epub 2007 Nov 26.
8
How long do the systemic and ventilatory responses to toluene diisocyanate persist in dermally sensitized mice?在经皮肤致敏的小鼠中,对甲苯二异氰酸酯的全身和通气反应会持续多长时间?
J Allergy Clin Immunol. 2008 Feb;121(2):456-463.e5. doi: 10.1016/j.jaci.2007.09.006. Epub 2007 Nov 5.
9
Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation.使用粘膜粘附性变应原制剂提高舌下免疫疗法的疗效。
J Allergy Clin Immunol. 2007 Aug;120(2):278-85. doi: 10.1016/j.jaci.2007.04.009. Epub 2007 May 25.
10
Sublingual immunotherapy reduces allergic symptoms in a mouse model of rhinitis.舌下免疫疗法可减轻鼻炎小鼠模型的过敏症状。
Clin Exp Allergy. 2007 Apr;37(4):488-97. doi: 10.1111/j.1365-2222.2006.02624.x.